Small scale pharmaceutical units in the country are facing an imminent closure owing to lack of business opportunities and hostile regulatory policies.
India's pharmaceutical industry is losing around Rs 500 crore (Rs 5 billion) annually on account of destruction of expired drugs, hitting the bottom line of drug manufacturers, especially the small and medium ones.
The move is expected to delay the introduction of low-priced medicines in the market.
The number of small units has come down drastically, as large companies have expanded their manufacturing capacity.